Molecular mechanism of renal lipid accumulation in diabetic kidney disease
Journal of Cellular and Molecular Medicine · 2024-06 · 28 (11)
DOI: 10.1111/jcmm.18364 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 05.06.2024. Verfasst von Zhengying Fang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Lipid Metabolism, Kidney. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, BLRD VA, National Institute of Health (NIH) / National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is a leading cause of end stage renal disease with unmet clinical demands for treatment. Lipids are essential for cell survival; however, renal cells have limited capability to metabolize overloaded lipids. Dyslipidaemia is common in DKD patients and renal ectopic lipid accumulation is associated with disease progression. Unveiling the molecular mechanism involved in renal lipid regulation is crucial for exploring potential therapeutic targets. In this review, we focused on the mechanism underlying cholesterol, oxysterol and fatty acid metabolism disorder in the context of DKD. Specific regulators of lipid accumulation in different kidney compartment and TREM2 macrophages, a lipid‐related macrophages in DKD, were discussed. The role of sodium‐glucose transporter 2 inhibitors in improving renal lipid accumulation was summarized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Barbara T. Murphy Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Renal Section, James J Peters Veterans Affair Medical Center, Bronx, New York, USA.
ORCID-Profile: John Cijiang He
Förderung
- NIDDK NIH HHS
- BLRD VA
- National Institute of Health (NIH) / National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- VA Merit Award
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Fang, Z., Liu, R., Xie, J., & He, J. C. (2024). Molecular mechanism of renal lipid accumulation in diabetic kidney disease. Journal of Cellular and Molecular Medicine, 28(11). https://doi.org/10.1111/jcmm.18364
Vancouver
Fang Z, Liu R, Xie J, He JC. Molecular mechanism of renal lipid accumulation in diabetic kidney disease. Journal of Cellular and Molecular Medicine. 2024;28(11). doi:10.1111/jcmm.18364
BibTeX
@article{Fang2024,
author = {Fang, Zhengying and Liu, Ruijie and Xie, Jingyuan and He, John Cijiang},
title = {Molecular mechanism of renal lipid accumulation in diabetic kidney disease},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {11},
doi = {10.1111/jcmm.18364}
}
EUVIMED